Linfomas
GLUN
![Foto de Linfomas](/img/uploaded/b9af73325528959212d2c665099d4e1f.jpg)
![Foto de Stony Brook University](/img/noimage_org.png)
Stony Brook University
Stony Brook, Estados UnidosPublications in collaboration with researchers from Stony Brook University (5)
2022
-
Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173Amice
Nucleic Acids Research, Vol. 50, Núm. 14, pp. 8093-8106
2021
-
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma
Future Oncology, Vol. 17, Núm. 11, pp. 1295-1310
2020
-
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial
The Lancet Haematology, Vol. 7, Núm. 7, pp. e511-e522
2019
-
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Blood, Vol. 133, Núm. 22, pp. 2401-2412
2012
-
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions
Blood, Vol. 120, Núm. 24, pp. 4802-4811